New Zealand markets open in 7 hours 43 minutes

Aridis Pharmaceuticals, Inc. (ARDS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0800+0.1400 (+7.22%)
At close: 04:00PM EST
2.1400 +0.06 (+2.88%)
Pre-market: 08:15AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
548
1,000
1,022
2,757
Operating expenses
Research development
33,601
16,956
24,083
23,000
Selling general and administrative
6,929
6,445
6,026
3,874
Total operating expenses
40,530
23,401
30,109
26,874
Operating income or loss
-39,982
-22,401
-29,087
-24,117
Interest expense
-
-
-
420
Total other income/expenses net
774
-9
-951
1,592
Income before tax
-39,206
-22,333
-29,681
-22,105
Income from continuing operations
-39,206
-22,333
-29,681
-22,105
Net income
-39,206
-22,333
-29,681
-22,105
Net income available to common shareholders
-43,333
-22,333
-29,681
-23,462
Basic EPS
-
-2.44
-3.51
-7.02
Diluted EPS
-
-2.44
-3.51
-7.02
Basic average shares
-
9,169
8,458
3,147
Diluted average shares
-
9,169
8,458
3,147
EBITDA
-
-22,064
-28,749
-23,834